These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19587369)

  • 1. Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1).
    Snehalatha C; Mary S; Selvam S; Sathish Kumar CK; Shetty SB; Nanditha A; Ramachandran A
    Diabetes Care; 2009 Oct; 32(10):1796-801. PubMed ID: 19587369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of primary prevention interventions when fasting and postglucose dysglycemia coexist: analysis of the Indian Diabetes Prevention Programmes (IDPP-1 and IDPP-2).
    Ramachandran A; Arun N; Shetty AS; Snehalatha C
    Diabetes Care; 2010 Oct; 33(10):2164-8. PubMed ID: 20519663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
    Viswanathan V; Clementina M; Nair BM; Satyavani K
    J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).
    Ramachandran A; Snehalatha C; Mary S; Mukesh B; Bhaskar AD; Vijay V;
    Diabetologia; 2006 Feb; 49(2):289-97. PubMed ID: 16391903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of strategies for primary prevention of diabetes on cardiovascular risk factors: results of the Indian Diabetes Prevention Programme.
    Snehalatha C; Mary S; Joshi VV; Ramachandran A
    Diab Vasc Dis Res; 2008 Mar; 5(1):25-9. PubMed ID: 18398809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial.
    Rissanen A; Howard CP; Botha J; Thuren T;
    Diabetes Obes Metab; 2012 Dec; 14(12):1088-96. PubMed ID: 22726220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal of medications leads to worsening of OGTT parameters in youth with impaired glucose tolerance or recently-diagnosed type 2 diabetes.
    Hannon TS; Edelstein SL; Arslanian SA; Caprio S; Zeitler PS; Buchanan TA; Ehrmann DA; Mather KJ; Tripputi M; Kahn SE; Nadeau KJ;
    Pediatr Diabetes; 2020 Dec; 21(8):1437-1446. PubMed ID: 32985775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin sensitivity and secretion in Arab Americans with glucose intolerance.
    Salinitri FD; Pinelli NR; Martin ET; Jaber LA
    Diabetes Technol Ther; 2013 Dec; 15(12):1019-24. PubMed ID: 23919587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic beta-cell function and insulin sensitivity in japanese subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes mellitus.
    Kanauchi M; Nakajima M; Saito Y; Kanauchi K
    Metabolism; 2003 Apr; 52(4):476-81. PubMed ID: 12701062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and β-cell function in subjects with long-term remission.
    Hu Y; Li L; Xu Y; Yu T; Tong G; Huang H; Bi Y; Weng J; Zhu D
    Diabetes Care; 2011 Aug; 34(8):1848-53. PubMed ID: 21680726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.
    Matsumoto K; Miyake S; Yano M; Ueki Y; Yamaguchi Y; Akazawa S; Tominaga Y
    Diabetes Care; 1997 Oct; 20(10):1562-8. PubMed ID: 9314636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.
    Miyazaki Y; Akasaka H; Ohnishi H; Saitoh S; DeFronzo RA; Shimamoto K
    Hypertens Res; 2008 Jul; 31(7):1357-63. PubMed ID: 18957806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome does not increase the risk of conversion of impaired glucose tolerance to diabetes in Asian Indians--Result of Indian diabetes prevention programme.
    Ramachandran A; Snehalatha C; Satyavani K; Sivasankari S; Vijay V
    Diabetes Res Clin Pract; 2007 May; 76(2):215-8. PubMed ID: 16982107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin sensitivity and pancreatic beta cell function changes during the transformation from normal to impaired glucose tolerance].
    Li J; Yan L; Chen LH; Li Y; Li F; Liu SL; Qi YQ; Cheng H
    Zhonghua Nei Ke Za Zhi; 2007 Oct; 46(10):842-5. PubMed ID: 18218239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of Durable Improvements in β-Cell Function Following Withdrawal of Pharmacological Interventions in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes.
    RISE Consortium
    Diabetes Care; 2019 Sep; 42(9):1742-1751. PubMed ID: 31178434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].
    Liu J; Li YB; Shao H; Li YX; Yuan YH; Xiao YB; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1252-5. PubMed ID: 17686259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol consumption and diabetes risk in the Diabetes Prevention Program.
    Crandall JP; Polsky S; Howard AA; Perreault L; Bray GA; Barrett-Connor E; Brown-Friday J; Whittington T; Foo S; Ma Y; Edelstein SL;
    Am J Clin Nutr; 2009 Sep; 90(3):595-601. PubMed ID: 19640960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes over time in glycemic control, insulin sensitivity, and beta-cell function in response to low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance.
    Retnakaran R; Qi Y; Harris SB; Hanley AJ; Zinman B
    Diabetes Care; 2011 Jul; 34(7):1601-4. PubMed ID: 21709296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Insulin and Metformin Versus Metformin Alone on β-Cell Function in Youth With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes.
    RISE Consortium
    Diabetes Care; 2018 Aug; 41(8):1717-1725. PubMed ID: 29941500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.